Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:EPPNASDAQ:GOODNASDAQ:HGENNYSE:INFA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEPPiShares MSCI Pacific ex Japan ETF$45.380.0%$43.94$38.44▼$49.29$1.89B0.84318,599 shs140,827 shsGOODGladstone Commercial$14.12+0.7%$14.77$12.67▼$17.88$646.09M1.17294,956 shs225,417 shsHGENHumanigen$0.00$0.00▼$0.24$24K-1.043.26 million shs2.06 million shsINFAInformatica$18.81+1.9%$18.09$15.65▼$32.51$5.69B1.062.11 million shs1.83 million shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEPPiShares MSCI Pacific ex Japan ETF0.00%+3.94%+2.55%+0.80%+7.79%GOODGladstone Commercial0.00%-0.35%-5.23%-14.01%+5.93%HGENHumanigen0.00%0.00%0.00%0.00%0.00%INFAInformatica0.00%+7.27%+3.81%-24.61%-41.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AN/AN/AN/AN/AN/AGOODGladstone Commercial2.8454 of 5 stars1.53.01.72.43.50.80.6HGENHumanigenN/AN/AN/AN/AN/AN/AN/AN/AINFAInformatica3.3234 of 5 stars4.11.00.00.02.14.21.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEPPiShares MSCI Pacific ex Japan ETF 2.88Moderate Buy$45.38N/AGOODGladstone Commercial 3.00Buy$15.006.23% UpsideHGENHumanigen 0.00N/AN/AN/AINFAInformatica 2.19Hold$24.1528.44% UpsideCurrent Analyst Ratings BreakdownLatest HGEN, INFA, EPP, and GOOD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025INFAInformaticaDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$20.00 ➝ $18.002/14/2025INFAInformaticaWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Equal Weight2/14/2025INFAInformaticaWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral2/14/2025INFAInformaticaBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/14/2025INFAInformaticaUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$30.00 ➝ $19.002/14/2025INFAInformaticaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$34.00 ➝ $24.002/14/2025INFAInformaticaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$38.00 ➝ $20.002/14/2025INFAInformaticaBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral2/14/2025INFAInformaticaDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$21.002/14/2025INFAInformaticaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Sector Perform$35.00 ➝ $19.00(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AN/AN/AN/AGOODGladstone Commercial$149.39M4.32$1.52 per share9.30$3.88 per share3.64HGENHumanigen$1.70M0.00N/AN/A($0.45) per share0.00INFAInformatica$1.64B3.47$0.74 per share25.28$7.38 per share2.55Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEPPiShares MSCI Pacific ex Japan ETFN/AN/A16.49∞N/AN/AN/AN/AN/AGOODGladstone Commercial$4.99M$0.2654.319.411.8216.09%15.16%2.18%5/7/2025 (Estimated)HGENHumanigen-$70.73MN/A0.00N/AN/AN/AN/AN/AN/AINFAInformatica$9.93M$0.03627.0427.254.440.61%5.76%2.62%5/7/2025 (Estimated)Latest HGEN, INFA, EPP, and GOOD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025GOODGladstone Commercial$0.34N/AN/AN/A$37.33 millionN/A5/7/2025Q1 2025INFAInformatica$0.22N/AN/AN/A$392.14 millionN/A2/18/2025Q4 2024GOODGladstone Commercial$0.11$0.35+$0.24$0.35$38.04 million$37.38 million2/13/2025Q4 2024INFAInformatica$0.38$0.21-$0.17$0.03$457.55 million$428.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEPPiShares MSCI Pacific ex Japan ETF$1.673.68%N/AN/AN/AGOODGladstone Commercial$1.208.50%+41.37%461.54%N/AHGENHumanigenN/AN/AN/AN/AN/AINFAInformaticaN/AN/AN/AN/AN/ALatest HGEN, INFA, EPP, and GOOD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/10/2025GOODGladstone Commercialmonthly$0.108.8%6/20/20256/20/20256/30/20254/9/2025GOODGladstone Commercialmonthly$0.108.8%6/20/20256/20/20256/30/20254/8/2025GOODGladstone Commercial$0.105/21/20255/21/20255/30/20254/21/2025GOODGladstone Commercial$0.108.5%4/21/20254/22/20254/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AGOODGladstone Commercial4.055.683.54HGENHumanigenN/AN/AN/AINFAInformatica0.752.172.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEPPiShares MSCI Pacific ex Japan ETF74.75%GOODGladstone Commercial45.51%HGENHumanigen4.55%INFAInformatica98.45%Insider OwnershipCompanyInsider OwnershipEPPiShares MSCI Pacific ex Japan ETFN/AGOODGladstone Commercial1.40%HGENHumanigen21.70%INFAInformatica48.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEPPiShares MSCI Pacific ex Japan ETFN/A41.70 millionN/ANot OptionableGOODGladstone Commercial7045.76 million43.52 millionOptionableHGENHumanigen6119.08 million93.24 millionNo DataINFAInformatica5,500302.60 million158.49 millionOptionableHGEN, INFA, EPP, and GOOD HeadlinesRecent News About These CompaniesInformatica Inc. (NYSE:INFA) EVP John Arthur Schweitzer Sells 11,503 SharesApril 26 at 5:28 AM | insidertrades.comMarshall Wace LLP Buys 192,906 Shares of Informatica Inc. (NYSE:INFA)April 25 at 4:14 AM | marketbeat.comWhich Is a Better Investment, Informatica Inc. or Open Text Corporation Stock?April 25 at 2:00 AM | aaii.comInformatica Continues Transition With Weak Revenue Growth (Downgrade)April 24, 2025 | seekingalpha.comInformatica and Carnegie Mellon University Partner to Drive Innovation in Generative AIApril 23, 2025 | itwire.comRenaissance Technologies LLC Takes $5.40 Million Position in Informatica Inc. (NYSE:INFA)April 22, 2025 | marketbeat.comInformatica Inc. (NYSE:INFA) Receives Average Recommendation of "Hold" from AnalystsApril 21, 2025 | marketbeat.com143,500 Shares in Informatica Inc. (NYSE:INFA) Acquired by Walleye Capital LLCApril 20, 2025 | marketbeat.comInformatica Inc. (NYSE:INFA) Receives Consensus Recommendation of "Hold" from AnalystsApril 20, 2025 | americanbankingnews.comCanada Pension Plan Investment Board Sells 9,065,609 Shares of Informatica Inc. (NYSE:INFA)April 19, 2025 | marketbeat.comInformatica (NYSE:INFA) Sees Strong Trading Volume - Here's What HappenedApril 18, 2025 | marketbeat.comDA Davidson Brokers Lower Earnings Estimates for InformaticaApril 18, 2025 | marketbeat.comFY2025 EPS Estimates for Informatica Lowered by AnalystApril 18, 2025 | americanbankingnews.comInformatica and Carnegie Mellon University Partner to Drive Innovation in Generative AI for Data ManagementApril 17, 2025 | finance.yahoo.comInformatica and Carnegie Mellon University Partner to Drive Innovation in Generative AI for ...April 17, 2025 | gurufocus.comInformatica and Carnegie Mellon University Partner to Drive Innovation in Generative AI for ...April 17, 2025 | gurufocus.comShannon River Fund Management LLC Sells 979,372 Shares of Informatica Inc. (NYSE:INFA)April 17, 2025 | marketbeat.comGeode Capital Management LLC Increases Position in Informatica Inc. (NYSE:INFA)April 17, 2025 | marketbeat.comDA Davidson Issues Pessimistic Forecast for Informatica (NYSE:INFA) Stock PriceApril 16, 2025 | marketbeat.comHarber Asset Management LLC Makes New $11.32 Million Investment in Informatica Inc. (NYSE:INFA)April 16, 2025 | marketbeat.comInvesco Ltd. Has $68.11 Million Stock Holdings in Informatica Inc. (NYSE:INFA)April 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldBy Thomas Hughes | April 14, 2025View Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldOptions Activity Points to More Volatility for Palantir StockBy Chris Markoch | April 7, 2025View Options Activity Points to More Volatility for Palantir StockAnalyst Targets Signal More Growth in CrowdStrike StockBy Chris Markoch | April 2, 2025View Analyst Targets Signal More Growth in CrowdStrike StockHGEN, INFA, EPP, and GOOD Company DescriptionsiShares MSCI Pacific ex Japan ETF NYSEARCA:EPP$45.38 -0.01 (-0.02%) As of 04/25/2025 04:10 PM EasterniShares MSCI Pacific ex Japan ET (the Fund), formerly iShares MSCI Pacific ex-Japan Index Fund, is an exchange-traded fund (ETF). The Fund seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australia, Hong Kong, New Zealand and Singapore markets, as measured by the MSCI Pacific ex-Japan Index (the Index). The Fund invests in a representative sample of securities that collectively has an investment profile similar to the underlying index. The securities selected are expected to have, in aggregate , investment characteristics, fundamental characteristics and liquidity measures similar to those of the underlying index. The Fund's investment advisor is BlackRock Fund Advisors.Gladstone Commercial NASDAQ:GOOD$14.12 +0.10 (+0.71%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$13.98 -0.14 (-0.99%) As of 04/25/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gladstone Commercial Corporation is a real estate investment trust focused on acquiring, owning, and operating net leased industrial and office properties across the United States. Including payments through January 2024, Gladstone Commercial has paid 229 consecutive monthly cash distributions on its common stock. Prior to paying distributions on a monthly basis, Gladstone Commercial paid five consecutive quarterly cash distributions. Gladstone Commercial has never skipped or deferred a distribution since its inception in 2003.Humanigen NASDAQ:HGENHumanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response. The company is developing lenzilumab, an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is associated with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1, as well as treats a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey. On January 3, 2024, Humanigen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Informatica NYSE:INFA$18.80 +0.36 (+1.92%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$18.78 -0.02 (-0.11%) As of 04/25/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Informatica Inc. develops an artificial intelligence-powered platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at enterprise scale worldwide. Its platform includes a suite of interoperable data management products, including data integration products to ingest, transform, and integrate data; API and application integration products that enable users to create and manage APIs and integration processes for app-to-app synchronization, business process orchestration, B2B partner management, application development, and API management; data quality and observability products to profile, cleanse, standardize, observe, and monitor data to deliver accurate, complete, and consistent data; and master data management products to create an authoritative single source of truth of business-critical data. The company's platform also includes customer and business 360 application that allow business analysts to create 360-degree views of business data domains like customer, product, supplier, reference, and finance with simplified business user experiences; data catalog products that enables customers to quickly find, access, and understand enterprise data using a simple Google-like search experience; governance and privacy products that help users define policies, govern data, and ensure compliance with industry and corporate policies; and a data marketplace that delivers cloud shopping experience for data consumers and enables data sharing and AI models across organizations to facilitate data-driven decision making. It also offers maintenance and professional services. The company sells its products through its direct sales team. The company was founded in 1993 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
